Li‐Hsin Shu

767 total citations · 1 hit paper
19 papers, 629 citations indexed

About

Li‐Hsin Shu is a scholar working on Complementary and alternative medicine, Molecular Biology and Pharmacology. According to data from OpenAlex, Li‐Hsin Shu has authored 19 papers receiving a total of 629 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Complementary and alternative medicine, 5 papers in Molecular Biology and 4 papers in Pharmacology. Recurrent topics in Li‐Hsin Shu's work include Traditional Chinese Medicine Analysis (6 papers), Computational Drug Discovery Methods (4 papers) and Cancer-related molecular mechanisms research (4 papers). Li‐Hsin Shu is often cited by papers focused on Traditional Chinese Medicine Analysis (6 papers), Computational Drug Discovery Methods (4 papers) and Cancer-related molecular mechanisms research (4 papers). Li‐Hsin Shu collaborates with scholars based in Taiwan. Li‐Hsin Shu's co-authors include Ching‐Yuan Wu, Yao‐Hsu Yang, Yu‐Ching Cheng, Yu‐Shih Lin, Jrhau Lung, Su Mei Wu, Jiahao Liu, Geng‐He Chang, Ming‐Shao Tsai and Cheng‐Ming Hsu and has published in prestigious journals such as International Journal of Molecular Sciences, Journal of Ethnopharmacology and Frontiers in Pharmacology.

In The Last Decade

Li‐Hsin Shu

19 papers receiving 624 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The potential chemical structure of anti‐SARS‐CoV‐2 RNA‐dependent RNA polymerase

2020 225 citations Jrhau Lung, Yu‐Shih Lin et al. Journal of Medical Virology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Li‐Hsin Shu Taiwan	10	207	140	127	125	109	19	629
Yu‐Shih Lin Taiwan	10	204 1.0×	136 1.0×	108 0.9×	111 0.9×	107 1.0×	21	576
Yogesh Kumar India	16	246 1.2×	104 0.7×	79 0.6×	59 0.5×	168 1.5×	57	850
S. M. Zahid Hosen Bangladesh	15	283 1.4×	65 0.5×	23 0.2×	22 0.2×	103 0.9×	47	564
Jianhua Miao China	17	572 2.8×	23 0.2×	81 0.6×	32 0.3×	28 0.3×	59	901
Sedigheh Asgary Iran	14	168 0.8×	39 0.3×	38 0.3×	30 0.2×	30 0.3×	35	741
Onur Bender Türkiye	14	222 1.1×	103 0.7×	20 0.2×	24 0.2×	58 0.5×	24	630
Md Sohel Bangladesh	13	286 1.4×	17 0.1×	67 0.5×	22 0.2×	56 0.5×	42	624
Hao Liang China	12	227 1.1×	99 0.7×	12 0.1×	36 0.3×	148 1.4×	25	573
Fangting Dong China	17	539 2.6×	53 0.4×	98 0.8×	15 0.1×	21 0.2×	43	798
Saroj Verma India	15	165 0.8×	51 0.4×	32 0.3×	22 0.2×	47 0.4×	41	609

Countries citing papers authored by Li‐Hsin Shu

Since Specialization

Citations

This map shows the geographic impact of Li‐Hsin Shu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li‐Hsin Shu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li‐Hsin Shu more than expected).

Fields of papers citing papers by Li‐Hsin Shu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Li‐Hsin Shu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li‐Hsin Shu. The network helps show where Li‐Hsin Shu may publish in the future.

Co-authorship network of co-authors of Li‐Hsin Shu

This figure shows the co-authorship network connecting the top 25 collaborators of Li‐Hsin Shu. A scholar is included among the top collaborators of Li‐Hsin Shu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Li‐Hsin Shu. Li‐Hsin Shu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Tsai, Ming-Yen, et al.. (2025). Antrodia cinnamomea Formula Suppresses Prostate Cancer Progression via Immune Modulation and PD-1/PD-L1 Pathway Inhibition. International Journal of Molecular Sciences. 26(6). 2684–2684. 2 indexed citations

Wu, Ching‐Yuan, et al.. (2024). The effect and mechanism of astragalus polysaccharides on T cells and macrophages in inhibiting prostate cancer. Biomedical Journal. 48(1). 100741–100741. 3 indexed citations

Lu, Chung‐Kuang, Jrhau Lung, Li‐Hsin Shu, et al.. (2024). The Inhibiting Effect of GB-2, (+)-Catechin, Theaflavin, and Theaflavin 3-Gallate on Interaction between ACE2 and SARS-CoV-2 EG.5.1 and HV.1 Variants. International Journal of Molecular Sciences. 25(17). 9498–9498. 3 indexed citations

Wu, Ching‐Yuan, et al.. (2023). Induction of ferroptosis and apoptosis in endometrial cancer cells by dihydroisotanshinone I. Heliyon. 9(11). e21652–e21652. 4 indexed citations

Wu, Ching‐Yuan, Yao‐Hsu Yang, Yu‐Shih Lin, et al.. (2023). The anti-SARS-CoV-2 effect and mechanism of Chiehyuan herbal oral protection solution. Heliyon. 9(7). e17701–e17701. 2 indexed citations

Tsai, Ming‐Shao, Yao‐Hsu Yang, Yu‐Shih Lin, et al.. (2022). Potential inhibitor for blocking binding between ACE2 and SARS-CoV-2 spike protein with mutations. Biomedicine & Pharmacotherapy. 149. 112802–112802. 9 indexed citations

Wu, Ching‐Yuan, et al.. (2022). The Role of MRE11 in the IL-6/STAT3 Pathway of Lung Cancer Cells. Current Issues in Molecular Biology. 44(12). 6132–6144. 4 indexed citations

Tsai, Ming‐Shao, Yao‐Hsu Yang, Yu‐Shih Lin, et al.. (2021). GB-2 blocking the interaction between ACE2 and wild type and mutation of spike protein of SARS-CoV-2. Biomedicine & Pharmacotherapy. 142. 112011–112011. 10 indexed citations

Wu, Ching‐Yuan, Yao‐Hsu Yang, Yu‐Shih Lin, et al.. (2021). Dihydroisotanshinone I induced ferroptosis and apoptosis of lung cancer cells. Biomedicine & Pharmacotherapy. 139. 111585–111585. 52 indexed citations

10.

Lung, Jrhau, Yu‐Shih Lin, Yao‐Hsu Yang, et al.. (2020). The potential chemical structure of anti‐SARS‐CoV‐2 RNA‐dependent RNA polymerase. Journal of Medical Virology. 92(6). 693–697. 225 indexed citations breakdown →

11.

Wu, Ching‐Yuan, et al.. (2020). GB-2 inhibits ACE2 and TMPRSS2 expression: In vivo and in vitro studies. Biomedicine & Pharmacotherapy. 132. 110816–110816. 28 indexed citations

12.

Lin, Yu‐Shih, Ching‐Yuan Wu, Yao‐Hsu Yang, et al.. (2019). Danshen Improves Survival of Patients With Breast Cancer and Dihydroisotanshinone I Induces Ferroptosis and Apoptosis of Breast Cancer Cells. Frontiers in Pharmacology. 10. 1226–1226. 94 indexed citations

13.

Wu, Su‐Mei, et al.. (2018). Effects of calcium and estrogen on the development of the ceratohyal cartilage in zebrafish (Danio rerio) larvae upon embryo and maternal cadmium exposure. Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology. 213. 47–54. 14 indexed citations

14.

Lin, Yu‐Shih, Yao‐Hsu Yang, Chun‐Liang Lin, et al.. (2018). Antrodia cinnamomea extract inhibits the proliferation of tamoxifen-resistant breast cancer cells through apoptosis and skp2/microRNAs pathway. BMC Complementary and Alternative Medicine. 18(1). 152–152. 32 indexed citations

15.

Yang, Yao‐Hsu, Chun‐Liang Lin, Wei‐Yu Lin, et al.. (2018). Dihydroisotanshinone I combined with radiation inhibits the migration ability of prostate cancer cells through DNA damage and CCL2 pathway. BMC Pharmacology and Toxicology. 19(1). 5–5. 22 indexed citations

16.

Wu, Su Mei, et al.. (2017). Anti-oxidative Responses on Hepatic Tissue of Zebrafish (Danio rerio) in a Short Duration of Sub-lethal Concentrations of Cadmium Exposure. Bulletin of Environmental Contamination and Toxicology. 98(5). 612–618. 9 indexed citations

17.

Huang, Wen‐Shih, Feng‐Che Kuan, Li‐Hsin Shu, et al.. (2017). Danshen improves survival of patients with colon cancer and dihydroisotanshinone I inhibit the proliferation of colon cancer cells via apoptosis and skp2 signaling pathway. Journal of Ethnopharmacology. 209. 305–316. 40 indexed citations

18.

Wu, Su Mei, Li‐Hsin Shu, & Jiahao Liu. (2016). Anti-oxidative functions of mt2 and smtB mRNA expression in the gills and brain of zebrafish (Danio rerio) upon cadmium exposure. Fish Physiology and Biochemistry. 42(6). 1709–1720. 7 indexed citations

19.

Wu, Su Mei, et al.. (2015). Anti-oxidative responses of zebrafish ( Danio rerio ) gill, liver and brain tissues upon acute cold shock. Comparative Biochemistry and Physiology Part A Molecular & Integrative Physiology. 187. 202–213. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact